Metabolomic analysis of two different models of delayed preconditioning

Journal of Molecular and Cellular Cardiology

Volumn 55, Issue 1, 2013, Pages 19-26

  Bravo, Claudio ^a   Kudej, Raymond K ^a,b   Yuan, Chujun ^a   Yoon, Seonghun ^a   Ge, Hui ^a   Park, Ji Yeon ^a   Tian, Bin ^a   Stanley, William C ^c   Vatner, Stephen F ^a   Vatner, Dorothy E ^a   Yan, Lin ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed cardiac ischemic preconditioning; Metabolomics

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ENERGY METABOLISM; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; HEART MUSCLE METABOLISM; HEART STRESS; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLIC STRESS; METABOLITE; METABOLOMICS; MYOCARDIAL HIBERNATION; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; THERAPY DELAY; TISSUE SECTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PRINCIPAL COMPONENT ANALYSIS; SWINE;

SUS;

EID: 84872684126     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.10.012     Document Type: Article

References (39)

1. Kuzuya T., Hoshida S., Yamashita N., Fuji H., Oe H., Hori M., et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993, 72:1293-1299.
2. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993, 88:1264-1272.
3. Kim S.J., Peppas A., Hong S.K., Yang G., Huang Y., Diaz G., et al. Persistent stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. Circ Res 2003, 92:1233-1239.
4. Shen Y.T., Depre C., Yan L., Park J.Y., Tian B., Jain K., et al. Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation 2008, 118:1961-1969.
5. Heyndrickx G.R., Millard R.W., McRitchie R.J., Maroko P.R., Vatner S.F. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975, 56:978-985.
6. Depre C., Kim S.J., John A.S., Huang Y., Rimoldi O.E., Pepper J.R., et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ Res 2004, 95:433-440.
7. Depre C., Park J.Y., Shen Y.T., Zhao X., Qiu H., Yan L., et al. Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. Am J Physiol Heart Circ Physiol 2010, 299:H752-H762.
8. Kudej R.K., Fasano M., Zhao X., Lopaschuk G.D., Fischer S.K., Vatner D.E., et al. Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia. Cardiovasc Res 2011, 92:394-400.
9. Braunwald E., Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982, 66:1146-1149.
10. Geft I.L., Fishbein M.C., Ninomiya K., Hashida J., Chaux E., Yano J., et al. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation 1982, 66:1150-1153.
11. Zhao X., Park J., Ho D., Gao S., Yan L., Ge H., et al. Cardiomyocyte overexpression of the alpha1A-adrenergic receptor in the rat phenocopies second but not first window preconditioning. Am J Physiol Heart Circ Physiol 2012, 302:H1614-H1624.
12. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
13. Skyschally A., Gres P., Hoffmann S., Haude M., Erbel R., Schulz R., et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007, 100:140-146.
14. Heusch P., Skyschally A., Leineweber K., Haude M., Erbel R., Heusch G. The interaction of coronary microembolization and ischemic preconditioning: a third window of cardioprotection through TNF-alpha. Arch Med Sci 2007, 3:83-92.
15. Bolli R., Bhatti Z.A., Tang X.L., Qiu Y., Zhang Q., Guo Y., et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 1997, 81:42-52.
16. Shen Y.T., Kudej R.K., Bishop S.P., Vatner S.F. Inotropic reserve and histological appearance of hibernating myocardium in conscious pigs with ameroid-induced coronary stenosis. Basic Res Cardiol 1996, 91:479-485.
17. Shen Y.T., Vatner S.F. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning?. Circ Res 1995, 76:479-488.
18. Camici P.G., Wijns W., Borgers M., De Silva R., Ferrari R., Knuuti J., et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997, 96:3205-3214.
19. Wijns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med 1998, 339:173-181.
20. Heusch G. Hibernating myocardium. Physiol Rev 1998, 78:1055-1085.
21. Heusch G., Schulz R., Rahimtoola S.H. Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 2005, 288:H984-H999.
22. Martin C., Schulz R., Rose J., Heusch G. Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. Cardiovasc Res 1998, 39:318-326.
23. Elsasser A., Muller K.D., Skwara W., Bode C., Kubler W., Vogt A.M. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J Am Coll Cardiol 2002, 39:1189-1198.
24. Jameel M.N., Li Q., Mansoor A., Xiong Q., Swingen C., Zhang J. Long-term preservation of myocardial energetic in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol 2011, 300:H836-H844.
25. Hu Q., Suzuki G., Young R.F., Page B.J., Fallavollita J.A., Canty J.M. Reductions in mitochondrial O(2) consumption and preservation of high-energy phosphate levels after simulated ischemia in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol 2009, 297:H223-H232.
26. McFalls E.O., Kelly R.F., Hu Q., Mansoor A., Lee J., Kuskowski M., et al. The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide. Am J Physiol Heart Circ Physiol 2007, 293:H2945-H2951.
27. Ingwall J.S. On the control of metabolic remodeling in mitochondria of the failing heart. Circ Heart Fail 2009, 2:275-277.
28. Ingwall J.S., Weiss R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 2004, 95:135-145.
29. McFalls E.O., Murad B., Liow J.S., Gannon M.C., Haspel H.C., Lange A., et al. Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia. Am J Physiol Heart Circ Physiol 2002, 282:H205-H211.
30. Wiggers H., Noreng M., Paulsen P.K., Bottcher M., Egeblad H., Nielsen T.T., et al. Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans. J Am Coll Cardiol 2001, 37:100-108.
31. Stoica S.C. High-energy phosphates and the human donor heart. J Heart Lung Transplant 2004, 23:S244-S246.
32. Sharov V.G., Afonskaya N.I., Ruda M.Y., Cherpachenko N.M., Pozin E., Markosyan R.A., et al. Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action. Biochem Med Metab Biol 1986, 35:101-114.
33. Cisowski M., Bochenek A., Kucewicz E., Wnuk-Wojnar A.M., Morawski W., Skalski J., et al. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery. J Cardiovasc Surg 1996, 37:75-80.
34. Prabhakar G., Vona-Davis L., Murray D., Lakhani P., Murray G. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization. J Am Coll Surg 2003, 197:786-791.
35. Elsasser A., Schaper J. Hibernating myocardium: adaptation or degeneration?. Basic Res Cardiol 1995, 90:47-48.
36. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation 2003, 108:1395-1403.
37. Mayr M., Liem D., Zhang J., Li X., Avliyakulov N.K., Yang J.I., et al. Proteomic and metabolomic analysis of cardioprotection: interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol 2009, 46:268-277.
38. De Souza A.I., Cardin S., Wait R., Chung Y.L., Vijayakumar M., Maguy A., et al. Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. J Mol Cell Cardiol 2010, 49:851-863.
39. Pinz I., Tian R., Belke D., Swanson E., Dillmann W., Ingwall J.S. Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a. J Biol Chem 2011, 286:10163-10168.